Can you put it on the scales, please? http://12yo.icu/ 11yo
The experimental drug, called alirocumab, is from apromising new class of injectable cholesterol fighters alsobeing developed by Amgen Inc and other drugmakers. Theywork by blocking a naturally occurring protein called PCSK9 andcould each garner annual sales of $3 billion or more, ifapproved, according to some industry analysts.